Research and Development

The Research and Development team at Enzyvant focuses on advancing innovative therapies for pulmonary arterial hypertension by conducting cutting-edge research, optimizing drug formulation, and ensuring robust manufacturing processes. This team collaborates closely with cross-functional departments to facilitate the preclinical and clinical development of novel biopharmaceuticals that aim to improve patient outcomes.